| human | Q5 |
| P166 | award received | Knight of the National Order of Merit | Q13422138 |
| P184 | doctoral advisor | Sandrine Silvente-Poirot | Q70587556 |
| P69 | educated at | Institute of Cardiovascular and Metabolic Diseases | Q30261394 |
| P108 | employer | French National Institute of Health and Medical Research | Q1474517 |
| P735 | given name | Céline | Q18147692 |
| Céline | Q18147692 | ||
| P106 | occupation | researcher | Q1650915 |
| P21 | sex or gender | female | Q6581072 |
| Q38974288 | A cell-permeable inhibitor to trap Gαq proteins in the empty pocket conformation |
| Q27011238 | Adult resident cardiomyocytes wake up: new axis for cardiac tissue regeneration |
| Q36283874 | Agonism, Antagonism, and Inverse Agonism Bias at the Ghrelin Receptor Signaling |
| Q35118220 | An essential role for RGS protein/Gαi2 interactions in B lymphocyte-directed cell migration and trafficking |
| Q53164772 | Analysis of Arrestin Recruitment to Chemokine Receptors by Bioluminescence Resonance Energy Transfer. |
| Q52650305 | Atomic force and electron microscopic-based study of sarcolemmal surface of living cardiomyocytes unveils unexpected mitochondrial shift in heart failure. |
| Q112737220 | Atomic force microscopy-single-molecule force spectroscopy unveils GPCR cell surface architecture |
| Q35351711 | Biased signaling at chemokine receptors |
| Q40420767 | Bioluminescence resonance energy transfer assays reveal ligand-specific conformational changes within preformed signaling complexes containing delta-opioid receptors and heterotrimeric G proteins. |
| Q38750062 | Biophysical properties of cardiomyocyte surface explored by multiparametric AFM. |
| Q35171170 | CODA-RET reveals functional selectivity as a result of GPCR heteromerization |
| Q26781612 | Cardiac cAMP: production, hydrolysis, modulation and detection |
| Q37309358 | Cardiac fibroblasts regulate sympathetic nerve sprouting and neurocardiac synapse stability |
| Q39326902 | Cardioprotective Angiotensin-(1-7) Peptide Acts as a Natural-Biased Ligand at the Angiotensin II Type 1 Receptor. |
| Q44099931 | Cardiotoxicity of chemotherapies |
| Q77122487 | Characterization of humoral immune responses induced by immunization with plasmid DNA expressing HIV-1 Nef accessory protein |
| Q39970283 | Cholesterol-dependent separation of the beta2-adrenergic receptor from its partners determines signaling efficacy: insight into nanoscale organization of signal transduction |
| Q92539005 | Coexpression of CCR7 and CXCR4 During B Cell Development Controls CXCR4 Responsiveness and Bone Marrow Homing |
| Q39993085 | Conformational rearrangements and signaling cascades involved in ligand-biased mitogen-activated protein kinase signaling through the beta1-adrenergic receptor. |
| Q58593716 | Deciphering biased inverse agonism of cangrelor and ticagrelor at P2Y receptor |
| Q39341454 | Deciphering biased-agonism complexity reveals a new active AT1 receptor entity. |
| Q38815819 | Delineating biased ligand efficacy at 7TM receptors from an experimental perspective |
| Q36470537 | Detecting and imaging protein-protein interactions during G protein-mediated signal transduction in vivo and in situ by using fluorescence-based techniques. |
| Q34654398 | Differential β₂-adrenergic receptor expression defines the phenotype of non-tumorigenic and malignant human breast cell lines |
| Q39048230 | Dosage-dependent regulation of cell proliferation and adhesion through dual β2-adrenergic receptor/cAMP signals. |
| Q35738220 | Dual agonist occupancy of AT1-R-α2C-AR heterodimers results in atypical Gs-PKA signaling |
| Q83389435 | Ephrin-B1 is a novel specific component of the lateral membrane of the cardiomyocyte and is essential for the stability of cardiac tissue architecture cohesion |
| Q91800705 | Evaluation of upconverting nanoparticles towards heart theranostics |
| Q28141454 | Evidence for a direct interaction between the penultimate aspartic acid of cholecystokinin and histidine 207, located in the second extracellular loop of the cholecystokinin B receptor |
| Q38932096 | Exercise training-induced modification in autonomic nervous system: An update for cardiac patients. |
| Q34653979 | Full and partial agonists of thromboxane prostanoid receptor unveil fine tuning of receptor superactive conformation and G protein activation. |
| Q34630128 | Functional enhancement of AT1R potency in the presence of the TPαR is revealed by a comprehensive 7TM receptor co-expression screen |
| Q35763177 | Functional selective oxytocin-derived agonists discriminate between individual G protein family subtypes |
| Q39827773 | Functional selectivity of natural and synthetic prostaglandin EP4 receptor ligands. |
| Q50524701 | G protein-coupled receptors, an unexploited animal toxin targets: Exploration of green mamba venom for novel drug candidates active against adrenoceptors. |
| Q52327561 | GHSR-D2R heteromerization modulates dopamine signaling through an effect on G protein conformation. |
| Q35062647 | Ghrelin receptor conformational dynamics regulate the transition from a preassembled to an active receptor:Gq complex |
| Q40423659 | Glycoprotein hormone receptors: link between receptor homodimerization and negative cooperativity |
| Q40585306 | Glycosylation-Dependent IFN-γR Partitioning in Lipid and Actin Nanodomains Is Critical for JAK Activation. |
| Q50647862 | Heterotrimeric G proteins form stable complexes with adenylyl cyclase and Kir3.1 channels in living cells. |
| Q42796314 | High tumorigenic potential of a constitutively active mutant of the cholecystokinin 2 receptor. |
| Q46482563 | High-intensity interval exercise improves vagal tone and decreases arrhythmias in chronic heart failure. |
| Q40970021 | Homologous regulation of the alpha2C-adrenoceptor subtype in human hepatocarcinoma, HepG2. |
| Q34399307 | Identification of a novel snake peptide toxin displaying high affinity and antagonist behaviour for the α2-adrenoceptors. |
| Q28191088 | Identification of tyrosine 189 and asparagine 358 of the cholecystokinin 2 receptor in direct interaction with the crucial C-terminal amide of cholecystokinin by molecular modeling, site-directed mutagenesis, and structure/affinity studies |
| Q38867105 | Mapping HA-tagged protein at the surface of living cells by atomic force microscopy |
| Q24300492 | Molecular organization and dynamics of the melatonin MT₁ receptor/RGS20/G(i) protein complex reveal asymmetry of receptor dimers for RGS and G(i) coupling |
| Q73626826 | Mutation of Asn-391 within the conserved NPXXY motif of the cholecystokinin B receptor abolishes Gq protein activation without affecting its association with the receptor |
| Q48056514 | Nanoscale structural mapping as a measure of maturation in the murine frontal cortex |
| Q56648608 | Nouveau dialogue entre récepteurs et protéines G trimériques : « une danse à corps enlacés » |
| Q48193375 | Partial Agonist and Biased Signaling Properties of the Synthetic Enantiomers J113863/UCB35625 at Chemokine Receptors CCR2 and CCR5. |
| Q37974268 | Probing heterotrimeric G protein activation: applications to biased ligands. |
| Q42595255 | Probing the activation-promoted structural rearrangements in preassembled receptor-G protein complexes. |
| Q34405296 | Real-time monitoring of receptor and G-protein interactions in living cells. |
| Q43560661 | Role of the ubiquitin-proteasome system in the regulation of P2Y13 receptor expression: impact on hepatic HDL uptake |
| Q92224442 | Short-term effects of a 3-week interval training program on heart rate variability in chronic heart failure. A randomised controlled trial |
| Q36157679 | Signaling Properties of Chemerin Receptors CMKLR1, GPR1 and CCRL2. |
| Q85783932 | Specific interactions between Epac1, β-arrestin2 and PDE4D5 regulate β-adrenergic receptor subtype differential effects on cardiac hypertrophic signaling |
| Q38319765 | Specific roles of G(i) protein family members revealed by dissecting SST5 coupling in human pituitary cells |
| Q57452868 | Structural evidence for a new elaborate 3D-organization of the cardiomyocyte lateral membrane in adult mammalian cardiac tissues |
| Q33186670 | Structure of cholecystokinin receptor binding sites and mechanism of activation/inactivation by agonists/antagonists. |
| Q36379426 | The experimental power of FR900359 to study Gq-regulated biological processes |
| Q53113693 | [Adult cardiomyocytes wake up: a big step towards cardiac regeneration]. |
| Q53107798 | [G-protein-coupled receptors plasticity and signalling]. |
| Q40740067 | alpha(2B)-Adrenergic receptors activate MAPK and modulate proliferation of primary cultured proximal tubule cells. |
| Q70587556 | Sandrine Silvente-Poirot | doctoral student | P185 |
Search more.